Show simple item record

dc.contributor.authorDe Franco, E
dc.contributor.authorSaint‐Martin, C
dc.contributor.authorBrusgaard, K
dc.contributor.authorKnight Johnson, AE
dc.contributor.authorAguilar‐Bryan, L
dc.contributor.authorBowman, P
dc.contributor.authorArnoux, J
dc.contributor.authorRønholt Larsen, A
dc.contributor.authorSanyoura, M
dc.contributor.authorGreeley, SAW
dc.contributor.authorCalzada‐León, R
dc.contributor.authorHarman, B
dc.contributor.authorHoughton, JAL
dc.contributor.authorNishimura‐Meguro, E
dc.contributor.authorLaver, TW
dc.contributor.authorEllard, S
dc.contributor.authordel Gaudio, D
dc.contributor.authorThybo Christesen, H
dc.contributor.authorBellanné‐Chantelot, C
dc.contributor.authorFlanagan, SE
dc.date.accessioned2020-02-14T09:29:47Z
dc.date.issued2020-02-06
dc.description.abstractThe most common genetic cause of neonatal diabetes and hyperinsulinism are pathogenic variants in ABCC8 and KCNJ11. These genes encode the subunits of the beta‐cell ATP sensitive potassium channel, a key component of the glucose‐stimulated insulin secretion pathway. Mutations in the two genes cause dysregulated insulin secretion; inactivating mutations cause an over‐secretion of insulin leading to congenital hyperinsulinism, whilst activating mutations cause the opposing phenotype, diabetes. This review focuses on variants identified in ABCC8 and KCNJ11, the phenotypic spectrum and the treatment implications for individuals with pathogenic variants.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipRoyal Societyen_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.description.sponsorshipNational Institutes of Health (NIH)en_GB
dc.description.sponsorshipAmerican Diabetes Associationen_GB
dc.description.sponsorshipKovler Family Foundationen_GB
dc.identifier.citationPublished online 6 February 2020en_GB
dc.identifier.doi10.1002/humu.23995
dc.identifier.grantnumber105636/Z/14/Zen_GB
dc.identifier.grantnumber16/0005407en_GB
dc.identifier.grantnumberP30 DK020595en_GB
dc.identifier.grantnumberK23 DK094866en_GB
dc.identifier.grantnumberR03 DK103096en_GB
dc.identifier.grantnumberR01 DK104942en_GB
dc.identifier.grantnumberUL1 TR000430en_GB
dc.identifier.grantnumber1-11-CT-41en_GB
dc.identifier.grantnumber1-17-JDF-008en_GB
dc.identifier.urihttp://hdl.handle.net/10871/40860
dc.language.isoenen_GB
dc.publisherWiley for Human Genome Variation Societyen_GB
dc.rights.embargoreasonUnder embargo until 6 February 2021 in compliance with publisher policy.en_GB
dc.rights© 2020 Wileyen_GB
dc.subjectNeonatal Diabetesen_GB
dc.subjectCongenital Hyperinsulinismen_GB
dc.subjectABCC8en_GB
dc.subjectKCNJ11en_GB
dc.subjectK-ATP channelen_GB
dc.titleUpdate of variants identified in the pancreatic beta‐cell K ATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetesen_GB
dc.typeArticleen_GB
dc.date.available2020-02-14T09:29:47Z
dc.identifier.issn1059-7794
exeter.article-numberhumu.23995en_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from Wiley via the DOI in this recorden_GB
dc.identifier.journalHuman Mutationen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
exeter.funder::Wellcome Trusten_GB
exeter.funder::Wellcome Trusten_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2020-02-06
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-02-14T09:24:45Z
refterms.versionFCDAM
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record